Prasad Betadpur, MD
Pulmonary Disease · Harrisonburg, VANPI 1871525543
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (37.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Covidien LP at 44.5% of the total. Reporting peaked in 2020 at $1,637 and has fallen 98.2% since, to $30 in 2025. That places this record below the midpoint for pulmonary disease clinicians in VA, where the typical reported total is $1,962.
Across 27 payments — averaging $72.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$874
- Sanofi$700
- Fisher & Paykel Healthcare Inc$113
- Aero US Inc$74
- Mylan Specialty L.p.$57
- Merck$42
- plus $107 from 4 others
What the payments were for
- Speaking & faculty fees$74038%
- Travel & lodging$74138%
- Food & beverage$47324%
- Education$131%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 13 | $874 |
| Sanofi | 2 | $700 |
| Fisher & Paykel Healthcare Inc | 2 | $113 |
| Aero US Inc | 1 | $74 |
| Mylan Specialty L.p. | 3 | $57 |
| Merck | 2 | $42 |
| Biofire Diagnostics, LLC | 1 | $40 |
| UCB, Inc. | 1 | $30 |
| Outset Medical Inc | 1 | $22 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Puritan Bennett$435
- McGRATH$306
How this compares
$1,966 in reported general payments places this provider in the 50th percentile of 317 pulmonary disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Harrisonburg
- Steven NathanFalls Church$1.5M
- Omar MinaiHopewell$1.3M
- Rabih HalabiFalls Church$604K
- Eric LibreAnnandale$302K
- Sujoy GillRichmond$296K
- Imre NothCharlottesville$256K
- Carlos SilvaChesapeake$245K
- Vijay SubramaniamWilliamsburg$228K
- Ellen VolkerCharlottesville$177K
- Himanshu DesaiChesapeake$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.